- Home
- BXP vs BAX Comparison
BXP vs BAX Comparison
Compare BXP & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BXP
- BAX
- Stock Information
- Founded
- BXP 1970
- BAX 1931
- Country
- BXP United States
- BAX United States
- Employees
- BXP N/A
- BAX N/A
- Industry
- BXP Real Estate Investment Trusts
- BAX Medical/Dental Instruments
- Sector
- BXP Real Estate
- BAX Health Care
- Exchange
- BXP Nasdaq
- BAX Nasdaq
- Market Cap
- BXP 13.1B
- BAX 15.1B
- IPO Year
- BXP 1997
- BAX N/A
- Fundamental
- Price
- BXP $74.62
- BAX $29.47
- Analyst Decision
- BXP Buy
- BAX Hold
- Analyst Count
- BXP 14
- BAX 10
- Target Price
- BXP $81.07
- BAX $40.90
- AVG Volume (30 Days)
- BXP 1.3M
- BAX 5.0M
- Earning Date
- BXP 01-28-2025
- BAX 02-06-2025
- Dividend Yield
- BXP 5.25%
- BAX 3.52%
- EPS Growth
- BXP 87.61
- BAX N/A
- EPS
- BXP 2.30
- BAX 0.21
- Revenue
- BXP $3,344,005,000.00
- BAX $15,062,000,000.00
- Revenue This Year
- BXP N/A
- BAX N/A
- Revenue Next Year
- BXP $1.65
- BAX $6.58
- P/E Ratio
- BXP $32.46
- BAX $123.91
- Revenue Growth
- BXP 4.47
- BAX 32.37
- 52 Week Low
- BXP $56.46
- BAX $28.62
- 52 Week High
- BXP $90.11
- BAX $44.01
- Technical
- Relative Strength Index (RSI)
- BXP 34.38
- BAX 34.00
- Support Level
- BXP $72.70
- BAX $28.62
- Resistance Level
- BXP $80.81
- BAX $30.29
- Average True Range (ATR)
- BXP 2.21
- BAX 0.76
- MACD
- BXP -0.71
- BAX -0.15
- Stochastic Oscillator
- BXP 18.13
- BAX 26.43
About BXP Boston Properties Inc.
BXP Inc. owns over 180 properties consisting of approximately 53 million rentable square feet of space. The portfolio is dominated by office buildings and is spread across major cities such as New York, Boston, San Francisco, Los Angeles, Seattle, and the Washington, D.C., region. The real estate investment trust also owns limited retail, hotel, and residential properties.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter has signed an agreement to sell its kidney care tools by early 2025.